A new trading day began on Monday, with Dyne Therapeutics Inc (NASDAQ: DYN) stock price up 3.34% from the previous day of trading, before settling in for the closing price of $12.58. DYN’s price has ranged from $6.36 to $46.81 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -59.45% over the past five years. Meanwhile, its annual earnings per share averaged -8.45%. With a float of $109.94 million, this company’s outstanding shares have now reached $114.34 million.
Let’s look at the performance matrix of the company that is accounted for 191 employees.
Dyne Therapeutics Inc (DYN) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Dyne Therapeutics Inc is 22.72%, while institutional ownership is 71.75%. The most recent insider transaction that took place on Jul 14 ’25, was worth 911,000. In this transaction CEO & President of this company bought 100,000 shares at a rate of $9.11, taking the stock ownership to the 242,179 shares. Before that another transaction happened on Jun 11 ’25, when Company’s Officer proposed sale 1,330 for $14.75, making the entire transaction worth $19,619.
Dyne Therapeutics Inc (DYN) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.96 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.85 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.52% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Here are Dyne Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 16.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.86, a number that is poised to hit -0.85 in the next quarter and is forecasted to reach -3.14 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Dyne Therapeutics Inc (NASDAQ: DYN) saw its 5-day average volume 2.46 million, a negative change from its year-to-date volume of 2.63 million. As of the previous 9 days, the stock’s Stochastic %D was 73.42%.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 74.86%, which indicates a significant decrease from 79.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.80 in the past 14 days, which was higher than the 0.80 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.38, while its 200-day Moving Average is $15.11. Nevertheless, the first resistance level for the watch stands at $13.56 in the near term. At $14.12, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.45. If the price goes on to break the first support level at $12.67, it is likely to go to the next support level at $12.34. Assuming the price breaks the second support level, the third support level stands at $11.78.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
With a market capitalization of 1.85 billion, the company has a total of 142,264K Shares Outstanding. Currently, annual sales are 0 K while annual income is -317,420 K. The company’s previous quarter sales were 0 K while its latest quarter income was -110,860 K.
